Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026)
Intuitive Surgical's (ISRG) quarterly Net Income towards Common Stockholders came in at $823.2 million in Q2 2026, up 23.94% year-on-year from $664.2 million in Q2 2025, and little changed quarter-over-quarter from $826.0 million in Q1 2026.
Intuitive Surgical (ISRG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Intuitive Surgical's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $823.2 million for Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 23.94% year-over-year to $823.2 million in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 20.23% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 23.06% from the prior year.
- Net Income towards Common Stockholders was little changed at $823.2 million in Q2 2026 per ISRG's latest filing, from $826.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $826.0 million in Q1 2026 and bottomed at $313.6 million in Q2 2022.
- The 5-year median for Net Income towards Common Stockholders is $559.0 million (2024), against an average of $556.9 million.
- Across the five-year window, Net Income towards Common Stockholders tumbled 40.04% in 2022 and jumped 81.38% in 2023, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at $336.7 million in 2022, then soared by 81.38% to $610.7 million in 2023, then grew by 12.66% to $688.0 million in 2024, then advanced by 16.21% to $799.5 million in 2025, then grew by 2.96% to $823.2 million in 2026.
- Per Business Quant, the three latest ISRG Net Income towards Common Stockholders figures stand at $823.2 million (Q2 2026), $826.0 million (Q1 2026), and $799.5 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 823.20 Mn |
| Mar 31, 2026 | 826.00 Mn |
| Dec 31, 2025 | 799.50 Mn |
| Sep 30, 2025 | 709.20 Mn |
| Jun 30, 2025 | 664.20 Mn |
| Mar 31, 2025 | 703.70 Mn |
| Dec 31, 2024 | 688.00 Mn |
| Sep 30, 2024 | 570.60 Mn |
| Jun 30, 2024 | 531.50 Mn |
| Mar 31, 2024 | 547.40 Mn |
| Dec 31, 2023 | 610.70 Mn |
| Sep 30, 2023 | 419.80 Mn |
| Jun 30, 2023 | 426.00 Mn |
| Mar 31, 2023 | 360.80 Mn |
| Dec 31, 2022 | 336.70 Mn |
| Sep 30, 2022 | 324.70 Mn |
| Jun 30, 2022 | 313.60 Mn |
| Mar 31, 2022 | 369.40 Mn |
| Dec 31, 2021 | 382.70 Mn |
| Sep 30, 2021 | 387.20 Mn |